Keyphrases
Transcription Factor
100%
Metformin
100%
Tumor Growth
100%
Pancreatic Cancer Cells
100%
Specificity Protein 1
100%
Cancer Cell Growth
100%
Cancer Tumor
100%
Regulated Genes
18%
PANC-1
18%
ZBTB10
18%
Knockdown
9%
Pancreas
9%
Mechanism of Action
9%
Induced Gene
9%
Tumor
9%
Vascular Endothelial Growth Factor
9%
MicroRNA
9%
Anticancer Activity
9%
RNA Interference
9%
B-cell Lymphoma 2 (Bcl-2)
9%
Transcription Factor Sp1
9%
Orthotopic Model
9%
Pancreatic Tumor
9%
Fatty Acid Synthase
9%
Survivin
9%
Repressor
9%
Drug Studies
9%
Induced Response
9%
Antidiabetic Drugs
9%
Chemotherapeutic Activity
9%
Pro-oncogenic
9%
Transcription Factor Proteins
9%
Chemopreventive
9%
Proteasomal Degradation
9%
Cyclin D1 (CCND1)
9%
Phosphatase
9%
MiR-27a
9%
Epidemiology Study
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Transcription Factors
100%
Tumor Progression
100%
Cell Growth
100%
Downregulation
66%
MicroRNA
33%
Vascular Endothelial Growth Factor
33%
Sp1 Transcription Factor
33%
Fatty Acid Synthase
33%
Bcl-2
33%
Proteasome
33%
Antineoplastic Activity
33%
Transcription Factor Sp4
33%
Repressor Protein
33%
Survivin
33%
Transcription Factor Sp3
33%
Cyclin D1
33%
RNAI
33%
Phosphatase
33%
Pharmacology, Toxicology and Pharmaceutical Science
Transcription Factors
100%
Metformin
100%
Cancer Growth
100%
Tumor Growth
100%
Pancreas Cancer
100%
Receptor
9%
Antidiabetic Agent
9%
Malignant Neoplasm
9%
Neoplasm
9%
Vasculotropin
9%
Pancreas Tumor
9%
Transcription Factor Sp1
9%
Fatty Acid Synthase
9%
microRNA
9%
Survivin
9%
Transcription Factor Sp4
9%
Transcription Factor Sp3
9%
Proteasome
9%
Cyclin D1
9%
Repressor Protein
9%
Phosphatase
9%
Immunology and Microbiology
Transcription Factors
100%
Cancer Cell
100%
Downregulation
66%
Pancreas
33%
Bcl-2
33%
Transcription Factor Sp1
33%
Vasculotropin
33%
Repressor Gene
33%
Proteasome
33%
Antineoplastic Activity
33%
Transcription Factor Sp4
33%
Transcription Factor Sp3
33%
Cyclin D1
33%
RNAI
33%